| Bioactivity | is an opioid peptide, acts as an agonist of opioid receptor[1][2]. |
| Target | Opioid receptor |
| Invitro | β-Casomorphin, human TFA induces contractions of the guinea-pig ileum myenteric plexus/longitudinal muscle preparation with an IC50 of 29 μM[1].β-Casomorphin, human TFA displaces 3H-spiperone from receptors in frontal cortex starting with 500 nM concentrations[2]. |
| Name | β-Casomorphin, human |
| CAS | 102029-74-3 |
| Sequence | Tyr-Pro-Phe-Val-Glu-Pro-Ile |
| Shortening | YPFVEPI |
| Formula | C44H61N7O11 |
| Molar Mass | 864.00 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Brantl V. Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur J Pharmacol. 1984 Oct 30;106(1):213-4. [2]. Koch G, et al. Opioid activities of human beta-casomorphins. Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):351-4. |